Kovitz Investment Group Partners LLC Purchases New Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Kovitz Investment Group Partners LLC acquired a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 17,976 shares of the company’s stock, valued at approximately $1,223,000.

Several other institutional investors have also bought and sold shares of GEHC. General Electric Co. acquired a new stake in GE HealthCare Technologies in the 2nd quarter valued at about $5,002,865,000. Capital Research Global Investors acquired a new stake in GE HealthCare Technologies in the 2nd quarter valued at about $4,027,040,000. BlackRock Inc. acquired a new stake in GE HealthCare Technologies in the 2nd quarter valued at about $2,334,660,000. State Street Corp acquired a new stake in GE HealthCare Technologies in the 2nd quarter valued at about $1,532,290,000. Finally, Geode Capital Management LLC acquired a new stake in GE HealthCare Technologies in the 2nd quarter valued at about $601,159,000. Institutional investors and hedge funds own 79.18% of the company’s stock.

Analyst Ratings Changes

GEHC has been the subject of a number of analyst reports. Morgan Stanley reduced their price objective on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an “equal weight” rating for the company in a research note on Monday, December 4th. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price objective for the company from $86.00 to $66.00 in a research note on Monday, November 27th. Jefferies Financial Group initiated coverage on shares of GE HealthCare Technologies in a research note on Thursday, November 30th. They set a “hold” rating and a $80.00 price objective for the company. Finally, Mizuho upped their price objective on shares of GE HealthCare Technologies from $94.00 to $96.00 and gave the company a “buy” rating in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $84.73.

Check Out Our Latest Analysis on GEHC

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $81.34 on Friday. The company has a market capitalization of $37.04 billion and a price-to-earnings ratio of 26.93. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $87.83. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.97. The business’s 50-day moving average is $75.05 and its 200-day moving average is $71.27.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last issued its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. The company had revenue of $5.20 billion for the quarter, compared to the consensus estimate of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.31 EPS. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 16th will be issued a $0.03 dividend. The ex-dividend date is Friday, January 12th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio is 3.97%.

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally.

Read More

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.